The high cost of medicine affords wealthier people a better opportunity for health than others. The recent “trend” of using Ozempic and other GLP-1 medications for weight loss highlighted this disparity. To prevent increasing costs, should pharmacies and physicians be allowed to compound ingredients of patented drugs owned by pharmaceutical companies even when there is no drug shortage?